Managed Healthcare Executive recently had a wide-ranging conversation with de Brantes about COVID-19, the healthcare sector and how the precipitious drops in utilization and provider revenue may affect the future of bundled payment and other alternative payment models.
Minnesota health insurance executive shares his belief that healthcare utilization peaks and valleys because of COVID-19, with MHE Senior Editor Peter Wehrwein.
As the world has gone virtual during the coronavirus pandemic, so has healthcare. Digital transformation has accelerated at warp speed, with virtual care delivery going from rare exception to operating norm almost overnight.
The novel coronavirus crisis has abruptly upended the operations and behaviors of both businesses and consumers-with such changes seemingly just the beginning.
Concerned about neglected healthcare and spike in deaths, physicians’ public service nationwide campaign urges senior patients, “don’t neglect your health” in a video.
Dr. Charity provides mental health support and advice to the growing number of burned out health workers.
Despite facing challenges such as limited access to personal protective equipment (PPE) following the COVID-19 outbreak, radiation oncology clinics quickly implemented safety and process enhancements that allowed them to continue caring for cancer patients.
Physician Performance LLC’s Weekly Zoom Clinical Call fills physicians in about the initial steps of palliative care.
Doctor.com announced the launch of VirtualVisit - a new telemedicine solution that enables any provider to start practicing medicine virtually in less than 5 minutes, completely free of charge.
It’s difficult for people seeking mental health treatment to get it right now. COVID-19 has effectively halted most non-essential doctors’ visits and accessing behavioral health treatment is even more challenging than in the past due to limitations with residential treatment and outpatient group sessions.
Scheduling automation and optimization enables better patient experience, increases staff satisfaction, and improves workforce efficiency.
In today’s COVID-19 environment, care management has become more important than ever. Currently, about one in four Americans live with multiple chronic conditions, and when one considers that 80% of outcomes are determined by nonclinical factors, it’s an indisputable claim that people need help between healthcare encounters.
The opioid epidemic has led doctors and patients to look for other ways to control pain, and they’re turning to technology for answers.
He was reluctant to take the CEO job, but VanTrieste has the unique nonprofit drug manufacturer surpassing its goals and possibly branching out into the retail market.
As the coronavirus pandemic swept the U.S., state governments mandated dental offices open only for emergency procedures. But in the coming weeks, some dental practices may resume regular appointments in individual states where businesses considered “essential” are allowed to re-open.
With the outbreak, American healthcare has been thrown into the embrace of healthtech. Now it has to get comfortable there.
COVID-19’s Impact on Health, Travel, Auto, Unemployment, Business, Restaurant, Special Events and Film/TV/Production Insurance, according to a report released by InsuranceQuotes.com.
A new study highlights the role a qualified specialty pharmacist can play in driving down costs across a health plan.
Patients and their oncologists are weighing the pros and cons of delaying treatment. Once the outbreak subsides, how might the practice of oncology change?
A study of patients with inflammatory conditions who were prescribed biologic disease-modifying anti-rheumatic drugs had lower rates of chronic opioid use if they were adherent to their biologic therapy, according to new research.
FDA authorizes first stand-alone, at-home test, plus other top COVID-19 news stories.
Medical and dental care in the United States are like estranged colleagues: nominally on the same team but rarely, if ever, in touch with each other. Some value-based payment arrangements may start to mend the rift, which could both improve overall health and reduce healthcare costs.
FDA today approved Tecentriq (atezolizumab) as an initial treatment for adults with metastatic non-small cell lung cancer (NSCLC) for certain patients with high programmed-death ligand-1 (PD-L1) expression, marking the fifth approval of the immunotherapy in lung cancer and the fourth in advanced NSCLC.
The purpose of biosimilar is simple: reduce healthcare costs, pure and simple. Here are 11 trends affecting biosimilars over the last year in the U.S.
Just as we’ve seen the entire healthcare landscape change in 2020 because of COVID-19, the world of biosimilars is ever-changing.
